Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No substantive changes to the study page were detected between the two screenshots; core content such as study design, eligibility criteria, primary and secondary outcomes, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:42:41.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:51:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Replace 'Plasma cell myeloma' with 'Multiple myeloma' and increment version from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T02:56:25.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page version is updated from v3.0.1 to v3.0.2, and the Back to Top link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:55:08.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-07T13:39:15.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a publication related to plasma cell myeloma, while several previous locations and related terms have been removed.
    Difference
    8%
    Check dated 2025-08-31T11:35:59.000Z thumbnail image

Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.